Luminist Capital LLC Exelixis, Inc. Transaction History
Luminist Capital LLC
- $57.6 Billion
- Q4 2024
A detailed history of Luminist Capital LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Luminist Capital LLC holds 50 shares of EXEL stock, worth $1,753. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$1,753% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
564Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.17 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.03 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$822 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$536 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$400 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.3B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...